Poly Medicure
Medical Instruments & Supplies · POLYMED
Mid CapHealthcareHigh Growth
Himanshu Baid
Managing Director · Visionary
Company DNA
Founder-Centric
About
Poly Medicure is a Mid Cap company in the Healthcare sector, listed on NSE as POLYMED. With a market cap of ₹13K Cr and revenue of ₹2K Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. Promoter-led high-growth entity where strategic vision is deeply tied to the founder's active management. Its strategic mandate: Requires R&D-focused leadership to scale its portfolio of complex medical devices in a high-growth sector.
FAQ
What kind of company is Poly Medicure?
Poly Medicure is a Mid Cap Healthcare company (POLYMED) in the High Growth phase with a market cap of ₹13K Cr. It is classified as Founder-Centric in culture.
What is Poly Medicure's culture and work environment like?
Poly Medicure has a Founder-Centric culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. Promoter-led high-growth entity where strategic vision is deeply tied to the founder's active management.
Who leads Poly Medicure?
Poly Medicure is led by Himanshu Baid (Managing Director), a Visionary leader with 30 years of experience.
What are Poly Medicure's financials?
Poly Medicure reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 21.8%. Operating margin: 23%. Market cap: ₹13K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationDisruptor
PaceStartup-Speed
PurposeMission-First
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
Promoter-led high-growth entity where strategic vision is deeply tied to the founder's active management.
Mandate
Requires R&D-focused leadership to scale its portfolio of complex medical devices in a high-growth sector.
Requires R&D-focused leadership to scale its portfolio of complex medical devices in a high-growth sector.
Financials
Revenue FY25₹2K Cr
PAT FY25₹339 Cr
Rev CAGR 5Y21.8%
OPM23%
NPM20.5%
ROE12.2%
ROCE13.5%
P/E36.9
Fwd P/E32.3
P/B4.4
D/E8.2
Mkt Cap₹13K Cr
Promoter66.9%
Institutional21.3%
Similar Culture
Could You Lead Poly Medicure?
Take the Genome Benchmark →